Search Results21-40 of  54

  • 2 / 3
  • 鈴木 重明 ID: 9000368408216

    Articles in CiNii:1

    • Neuromuscular complications after the treatment with immune checkpoint inhibitors (2017)
  • 鈴木 重明 ID: 9000370745166

    慶應義塾大学医学部神経内科 (2017 from CiNii)

    Articles in CiNii:1

    • 炎症性筋疾患の自己抗体:Update (2017)
  • 鈴木 重明 ID: 9000375879177

    慶應義塾大学医学部 神経内科 (2017 from CiNii)

    Articles in CiNii:1

    • WS1-2 筋炎・心筋炎を合併する重症筋無力症 (2017)
  • 鈴木 重明 ID: 9000380433165

    Articles in CiNii:1

    • 臨床各論 重症筋無力症・筋炎(Neuromuscular complications after the treatment with immune checkpoint inhibitors) (特集 免疫チェックポイント阻害薬 : 免疫学から理解する副作用) (2017)
  • 鈴木 重明 ID: 9000388514112

    慶應義塾大学医学部神経内科 (2018 from CiNii)

    Articles in CiNii:1

    • 免疫チェックポイント阻害薬による重症筋無力症 (2018)
  • 鈴木 重明 ID: 9000390917342

    Articles in CiNii:1

    • Immune Checkpoint Inhibitors and Neuromuscular Adverse Events (2018)
  • 鈴木 重明 ID: 9000397653662

    Articles in CiNii:1

    • Immune checkpoint inhibitors and neuromuscular disorders (2018)
  • 鈴木 重明 ID: 9000398287575

    Articles in CiNii:1

    • Immune checkpoint inhibitors and neuromuscular adverse events (2018)
  • 鈴木 重明 ID: 9000399820012

    Articles in CiNii:1

    • 多発筋炎・皮膚筋炎 (特集 免疫性・炎症性神経疾患 : 病態解明から疾患修飾薬開発まで) -- (筋疾患) (2016)
  • SUZUKI S. ID: 1000050276242

    Articles in CiNii:26

    • Alteration of cAMP-mediated signal transduction in cerebral ischemia : Binding activity of PKA and phosphorylation of CREB (1999)
    • 実験的脳虚血における interleukin-6 と leukemia inhibitory factor の発現 (2001)
    • Targets of treatment in the acute phase of cerebral infarction (2001)
  • SUZUKI Shigeaki ID: 9000000339614

    川崎市立川崎病院内科 (1996 from CiNii)

    Articles in CiNii:3

    • MRIにて両側大脳灰白質の全周に層状壊死を認めた低酸素脳症の1例 (1996)
    • A case of cerebral fat embolism - Serial proton MR specroscopy - (1996)
    • Cerebral metabolic disturbance in hypoxic encephalopathy : evaluation with H-1 MR spectroscopy (1996)
  • SUZUKI Shigeaki ID: 9000258043841

    Division of Neurology, Department of Internal Medicine, Keio University School of Medicine (2009 from CiNii)

    Articles in CiNii:1

    • Retrospective analysis of posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation (2009)
  • SUZUKI Shigeaki ID: 9000399223671

    Department of Neurology, Keio University School of Medicine (2018 from CiNii)

    Articles in CiNii:1

    • Successful Treatment with Nivolumab and Concomitant Radiation Therapy Under Control of Autoimmune Diseases (2018)
  • SUZUKI Shigeaki ID: 9000399811765

    Dai Nippon Toryo Co. Ltd. (2019 from CiNii)

    Articles in CiNii:1

    • Applications of Black Nanoparticles in Sensing Technology (2019)
  • Suzuki Shigeaki ID: 9000253466110

    Department of Internal Medicine|Department of Internal Medicine, Keio University Ise Keio Hospital (1996 from CiNii)

    Articles in CiNii:1

    • A case of cerebral fat embolism. Serial proton MR spectroscopy. (1996)
  • Suzuki Shigeaki ID: 9000258059038

    Department of Neurology, Keio University School of Medicine (2011 from CiNii)

    Articles in CiNii:1

    • Recurrent syncope due to sick sinus syndrome in a patient with myasthenia gravis associated with thymoma (2011)
  • Suzuki Shigeaki ID: 9000258059093

    Department of Neurology, Keio University School of Medicine (2011 from CiNii)

    Articles in CiNii:1

    • Anti-SRP myopathy (2011)
  • Suzuki Shigeaki ID: 9000258059906

    Department of Neurology, Keio University School of Medicine (2012 from CiNii)

    Articles in CiNii:1

    • New clinical entity of myasthenia gravis with autoimmune targets of heart and skeletal muscles (2012)
  • Suzuki Shigeaki ID: 9000258060032

    Department of Neurology, Keio University School of Medicine (2012 from CiNii)

    Articles in CiNii:1

    • Anti-SRP myopathy: different entity from myositis (2012)
  • Suzuki Shigeaki ID: 9000258060106

    Department of Neurology, Keio University School of Medicine (2012 from CiNii)

    Articles in CiNii:1

    • Directions for use of corticosteroids and calcineurin inhibitors against generalized myasthenia gravis: therapeutic strategies that can lead to early improvements and veer away from high-dose oral corticosteroids (2012)
  • 2 / 3
Page Top